
On Tuesday, the European Union announced that it was ordering 110,000 vaccine doses for monkeypox but did not name the drugmaker the deal was signed with.
Bavarian Nordic is now reporting that it is the supplier, and subsequently raises its financial expectations for the full year for the fourth time in four weeks, according to a company press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app